Composition comprising an elastomer GEL and hydrophobic silica particles
Hydrophobic silica particles in crosslinked polyester elastomer gels create stable, homogeneous cosmetic compositions with good sensory qualities and UV protection, addressing environmental concerns and sensory challenges in existing formulations.
Patent Information
- Application Number
- PCT/EP2026/063301
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-09
- Filing Date
- 2026-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
Existing cosmetic and dermatological compositions face challenges in achieving stable, homogeneous formulations with good sensory qualities, particularly in the presence of volatile solvents, while also addressing environmental concerns by reducing petrochemical use.
Incorporating hydrophobic silica particles into compositions containing crosslinked polyester elastomer gels, which are stable and homogeneous, even with volatile solvents, providing non-greasy, non-sticky, and pleasant sensory experiences.
The compositions are stable over time, exhibit good cosmetic properties, and offer high UV screening efficiency, with a pleasant feel and easy application, while promoting the use of renewable materials.
Smart Images

Figure PCTXMLIB-APPB-I000001 
Figure PCTXMLIB-APPB-I000002 
Figure PCTXMLIB-APPB-I000003
Abstract
Description
Composition comprising an elastomer gel and hydrophobic silica particles
[0001] The present invention relates to a composition, and in particular a cosmetic or dermatological composition, comprising an elastomer gel, containing at least one crosslinked polyester elastomer (also referred to hereinafter as the elastomer) and at least one solvent, and hydrophobic silica particles, and to the use of said composition in the cosmetic and dermatological fields, in particular for caring for and treating keratin materials, and notably for caring for, protecting and / or making up the skin of the body or the face, or for hair care.
[0002] Cosmetic or dermatological products are praised for their effectiveness but also for their sensory qualities. Therefore, in order to meet the requirements of consumers, it is necessary to obtain cosmetic or dermatological compositions having good sensory properties, more particularly ease of application of the product and a pleasant, non-greasy and non-sticky feel.
[0003] It is known practice to use silicones to obtain cosmetic or dermatological products with appropriate sensory qualities, in particular to obtain non-greasy and non-sticky, non-shiny products, with good slip and a cushion effect. In particular, silicone gels based on silicone elastomers are commonly added in various cosmetic or dermatological care formulations to improve their sensory performance, texture, rheology and optical performance.
[0004] However, the formulation of cosmetic products whose design and development take account of environmental issues is becoming a major preoccupation for helping meet the challenges facing the planet. It thus proves essential to propose more sustainable compositions, thereby making it possible to respond to these environmental issues, by notably reducing the use of compounds of petrochemical origin.
[0005] To meet this requirement, the company Momentive, in its patent application WO 2024 / 206504, proposes polyester elastomers obtained by the reaction of an activated polycarboxylic acid and a polyol. These polymers have good rheological properties and make it possible to improve the sensory qualities of cosmetic or dermatological compositions.
[0006] However, the introduction of this type of polymer into cosmetic or dermatological compositions in order to obtain a stable and homogeneous composition is not always easy, in particular in the presence of volatile solvents such as volatile hydrocarbons or ethanol, which may be used to provide lightness to the products.
[0007] Surprisingly, the applicant has found that specific silicas, more particularly hydrophobic silicas, such as silica aerogel particles, make it possible to obtain stable and homogeneous compositions comprising a crosslinked polyester elastomer gel, even in the presence of volatile solvents such as volatile hydrocarbons or ethanol. This discovery forms the basis of the invention.
[0008] Accordingly, the invention aims to propose a stable formulation with good cosmetic properties and a better carbon footprint, notably by promoting the use of renewable starting materials and / or those with a good naturalness index and / or of natural origin, while at the same time reducing the use of compounds of petrochemical origin.
[0009] Thus, in accordance with one of the subjects of the present invention, a composition, in particular a cosmetic or dermatological composition, is now proposed that comprises an elastomer gel, containing at least one crosslinked polyester elastomer (also referred to hereinafter as the elastomer) and at least one solvent, and hydrophobic silica particles.
[0010] The present invention makes it possible in particular to obtain compositions, and in particular cosmetic or dermatological compositions, which are stable during preparation and over time, which are light and have good sensory qualities, and particularly which are non-greasy and non-sticky.
[0011] The compositions in accordance with the invention have a satisfactory, and preferably pleasant, silky feel, especially when applied to the skin. In particular, the present invention aims to provide a composition, in particular a cosmetic composition, which has a light texture, a spreading behavior, a penetration rate and a skin feel that are suitable, in particular non-greasy and non-sticky, and which also has optical properties, particular so as to enable a soft-focus or matting effect to be obtained.
[0012] This possibility is particularly advantageous for compositions comprising at least one UV screening agent.
[0013] It is known, indeed, that radiation with a wavelength of between 280 nm and 400 nm enables tanning of the human epidermis and that radiation with a wavelength of between 280 and 320 nm, known under the name UVB rays, harms the development of a natural tan. Exposure is also liable to induce impairment of the biomechanical properties of the epidermis, which is reflected by the appearance of wrinkles, leading to premature aging of the skin.
[0014] It is also known that UVA rays with a wavelength of between 320 and 400 nm penetrate more deeply into the skin than UVB rays. UVA rays bring about immediate and persistent tanning of the skin. Daily exposure to UVA rays, even of short duration, under normal conditions can result in damage to the collagen fibers and the elastin, which is reflected by a modification of the microrelief of the skin, the appearance of wrinkles and uneven pigmentation (liver spots, nonuniformity of the complexion).
[0015] Protection against UVA and UVB radiation is thus necessary. An effective photoprotective product must protect against both UVA and UVB radiation.
[0016] Many photoprotective compositions have been proposed to date to overcome the effects induced by UVA and / or UVB radiation. They mostly contain a combination of several organic or inorganic UV screening agents, conveyed in an oily phase and / or in an aqueous phase, as active anti-UV agent, and are generally proposed in a presentation form of emulsion or gel type.
[0017] It is also known that high contents of screening agents are required to achieve high levels of screening efficiency.
[0018] However, high contents of UV screening agents do not lend themselves to easy production of compositions having a stabilized and pleasant texture. In particular, there remains a need for a photoprotective composition with a high level of UV protection, endowed with good sensory properties, especially being easy to spread, non-greasy, non-sticky and having in addition a cushion effect on the skin, or even a matting effect.
[0019] The applicant has also found that specific silicas, more particularly hydrophobic silicas, such as silica aerogel particles, made it possible to obtain sunscreen compositions comprising a crosslinked polyester elastomer gel which are stable and homogeneous at preparation and over time, which have good sensory qualities, in particular which are non-greasy and non-sticky, which spread easily on the skin, and which make it possible to obtain good sun protection.
[0020] Thus, in accordance with one of the subjects of the present invention, a composition, in particular a cosmetic or dermatological composition, is now proposed that comprises an elastomer gel containing at least one crosslinked polyester elastomer (also referred to hereinafter as the elastomer) and at least one solvent, hydrophobic silica particles, and at least one UV screening agent.Disclosure of the invention
[0021] Thus, one subject of the present invention is a composition, in particular a cosmetic or dermatological composition, comprising:(a) an elastomer gel containing at least one crosslinked polyester elastomer (also referred to hereinafter as the elastomer) and at least one solvent; and(b) hydrophobic silica particles.
[0022] This composition may optionally comprise at least one UV screening agent, preferably at least one lipophilic organic UV screening agent and / or at least one inorganic UV screening agent.
[0023] The present invention makes it possible to obtain homogeneous compositions, and in particular cosmetic or dermatological compositions, which are stable over time, exhibiting good cosmetic properties, in particular better sensory properties. When it comprises at least one UV screening agent, the composition also provides good UV screening efficiency.
[0024] The present invention also relates to a non-therapeutic cosmetic process for caring for and / or making up a keratin material, comprising the application, to the surface of said keratin material, of at least one composition according to the invention as defined above.
[0025] The invention also relates to a non-therapeutic cosmetic process for limiting the darkening of the skin and / or improving the color and / or uniformity of the complexion, comprising the application, to the surface of the keratin material, of at least one composition as defined previously.
[0026] The invention also relates to a non-therapeutic cosmetic process for preventing and / or treating the signs of aging of a keratin material, comprising the application, to the surface of the keratin material, of at least one composition as defined previously.
[0027] The composition in accordance with the invention is stable and homogeneous. For the purposes of the present invention, the term “stable and homogeneous” refers to a composition which does not exhibit phenomena such as salting out or phase separation on a macroscopic scale, or such as coalescence or Ostwald ripening on a microscopic scale, during preparation and over time.
[0028] The composition in accordance with the invention shows good stability. This stability can be evaluated macroscopically and / or microscopically, after storage for 24 hours, one week, one month, or two months, at room temperature (25°C), at 4°C, at 45°C or at 55°C. A stable composition generally maintains its pleasantness and its sensory signature on application over time. More specifically, the stability of a composition can be evaluated qualitatively for example by the absence of any phenomenon of phase separation / salting out or appearance of crystals on a macroscopic and / or microscopic scale, or quantitatively through the monitoring of the change in parameters such as pH and viscosity and changes in color and / or odor.
[0029] In the context of the invention, the screening efficiency can be evaluated from the evaluation of SPF and UVAPF.
[0030] For the purposes of the present invention, the term “SPF” means the sun protection factor, which measures the level of protection against UVB rays. The SPF value corresponds to the ratio between the minimum time it takes to sunburn with an antisun composition to the time it takes without a product. More specifically, the “SPF” is defined in the articleA new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum, J. Soc. Cosmet. Chem., 40, 127-133 (May / June 1989).
[0031] The SPF (sun protection factor) may be evaluatedin vitrousing the Labsphere® spectrophotometer. This protocol is described in standard ISO 23675:2024.
[0032] The sun protection factor (SPF) of compositions may also be evaluatedin vivoaccording to the protocol ISO / EN 24444: 2019 “Cosmetics - Sun protection test methods -in vivodetermination of the sun protection factor (SPF)”.
[0033] For the purposes of the present invention, the term “UVAPF” means the index characterizing the protection against UVA rays. In particular, this index can be measuredin vivoaccording to the “PPD” (Persistent Pigment Darkening) method, protocol ISO-24442:2022, and measures the color of the skin observed 2 to 4 hours after exposure to UVA rays. The protection against UVA rays can also be evaluatedin vitrousing the Labsphere® spectrophotometer. The plate is the material to which the antisun composition is applied. For this protocol, poly(methyl methacrylate) (PMMA) plates have proved to be ideal. The ISO 24443:2021 protocol describes such anin vitromethod.
[0034] Other features, aspects and advantages of the invention will become apparent on reading the detailed description that is to follow.
[0035] The composition according to the invention is intended for topical application and thus contains a physiologically acceptable medium. The term “physiologically acceptable medium” means here a medium that is compatible with keratin materials.
[0036] In the context of the present invention, the term “keratin material” notably means the skin, the scalp, keratin fibers such as the eyelashes, the eyebrows, head hair and body hair, the nails, and mucous membranes such as the lips, and more particularly the skin and mucous membranes (of the body, face, area around the eyes, eyelids or lips, preferably of the body, face and lips).
[0037] In the text hereinbelow, unless otherwise indicated, the limits of a range of values are included in that range, notably in the expressions “between” and “ranging from ... to ...”.
[0038] Moreover, the expressions “at least one” and “at least” used in the present description are equivalent to the expressions “one or more” and “greater than or equal to”, respectively.
[0039] According to the invention, the term “preventing” or “prevention” means reducing the risk of occurrence or slowing down the occurrence of a given phenomenon, namely, according to the present invention, the signs of aging of a keratin material.Detailed description of the inventionElastomer gel
[0040] The composition in accordance with the invention comprises an elastomer gel. The elastomer gel generally comprises at least one elastomer. Such elastomers are especially described in document WO2024206504A1.
[0041] In certain particular embodiments, the elastomer gel comprises a polyester elastomer containing a reaction product of:(i) at least one dicarboxylic acid or tricarboxylic acid;(ii) at least one monocarboxylic acid; and(iii) at least one polyol;where the one or more dicarboxylic acids are chosen from the compounds of formula (IA): in which:R1A represents a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the one or more tricarboxylic acids are chosen from the compounds of formula (IB): in which:R1B is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the one or more monocarboxylic acids are chosen from the compounds of formula (II): in which:R2 is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;and the one or more polyols are chosen from the compounds of formula (III): in which:R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group, a C3-C50 heteroalkenyl group, a C3-C50 cyclic group or a C3-C50 heterocyclic group; andn is an integer between 2 and 10.
[0042] According to a particular embodiment, the crosslinked polyester elastomer gel is present in an amount of between 0.1% and 50% by weight, preferably between 0.2% and 30% by weight, preferentially between 0.3% and 15% by weight, more preferentially between 0.5% and 10% by weight, and even more preferentially between 1% and 5% by weight, relative to the weight of the cosmetic composition.
[0043] According to a particular embodiment of the invention, the composition contains an elastomer gel comprising a crosslinked polyester elastomer of polyglyceryl-2 isostearate / dilinoleate dimer copolymer. According to a preferred embodiment, the elastomer gel comprises 30% of polyglyceryl-2 isostearate / dilinoleate dimer copolymer in a solvent comprising coco-caprylate / caprate and squalane.Active elastomer agent
[0044] As set out above, the amount of elastomer gel present in the cosmetic composition is between 0.1% and 50% by weight relative to the total weight of the cosmetic composition. Thus, in the particular case where the concentration of the active crosslinked polyester elastomer agent in the elastomer gel is about 30%, the amount of the active crosslinked polyester elastomer agent is between 0.03% and 15% by weight, relative to the total weight of the cosmetic composition.
[0045] The elastomer gel comprises an elastomer chosen from the elastomers included in disclosure WO2024206504A1, and in some embodiments comprises a reaction product of:(i) at least one dicarboxylic acid or tricarboxylic acid;(ii) at least one monocarboxylic acid; and(iii) at least one polyol;where the one or more dicarboxylic acids are chosen from the compounds of formula (IA): in which:R1A is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the one or more tricarboxylic acids are chosen from the compounds of formula (IB): in which:R1B is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the one or more monocarboxylic acids are chosen from the compounds of formula (II): in which:R2 is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;and the one or more polyols are chosen from the compounds of formula (III): in which:R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group, a C3-C50 heteroalkenyl group, a C3-C50 cyclic group or a C3-C50 heterocyclic group; andn is an integer from 2 to 10.
[0046] According to a preferred embodiment, the elastomer gel comprises a polyglyceryl-2 isostearate / dilinoleate dimer copolymer.
[0047] Thus, in various embodiments, the amount of active crosslinked polyester elastomer agent is between 0.03% and 15% by weight, preferably between 0.06% and 9% by weight, preferentially between 0.09% and 4.5% by weight, more preferentially between 0.15% and 3% by weight, and even more preferentially between 0.3% and 1.5% by weight of the cosmetic composition.
[0048] In some embodiments, the composition may include or exclude one or more additional elastomers or emulsifiers.
[0049] Reference is made to WO2024206504A1,Polyester elastomers based on dicarboxylic acid or tricarboxylic acid, monocarboxylic acid and polyol for cosmetic and personal care applications, which provides polyester elastomers, compositions and methods for preparing these elastomers and compositions.
[0050] The crosslinked polyester elastomers comprise the reaction product of at least one dicarboxylic or tricarboxylic acid, at least one monocarboxylic acid and at least one polyol. In one way, the polyester elastomers are prepared by an esterification reaction between at least one di- or tri-carboxylic acid, at least one mono-carboxylic acid, and at least one polyol that creates a crosslinked polymer structure. The polyester elastomers can further be swollen under shear force with a low molecular weight emollient or solvent to form a uniform polyester gel or paste having a wide viscosity range. These elastomers are expected to provide superior performance advantages, such as improved sensory, structuring and rheological performance over their analogous elastomers disclosed above. In another aspect, this invention relates to a cosmetic or dermatological composition containing high-purity polyester elastomers.
[0051] First, the polyester elastomer comprises the reaction product of:(i) at least one dicarboxylic acid or tricarboxylic acid;(ii) at least one monocarboxylic acid; and(iii) at least one polyol.
[0052] In one way, the elastomer is prepared by reacting:(i) at least one dicarboxylic acid of formula (IA): in which:R1A is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group; orat least one tricarboxylic acid of formula (IB): in which:R1B is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;(ii) at least one monocarboxylic acid of formula (II): in which:R2 is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group; and(iii) at least one polyol of formula (III): in which:R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group, a C3-C50 heteroalkenyl group, a C3-C50 cyclic group or a C3-C50 heterocyclic group; andn is an integer between 2 and 10.
[0053] In the context of the invention, the term “alkyl” refers to a linear or branched aliphatic hydrocarbon chain which is saturated, meaning that it does not contain a multiple bond. In particular, a C2-C52 alkyl radical is a linear or branched aliphatic hydrocarbon chain which is saturated, meaning that it does not contain a multiple bond, and contains from 2 to 52 carbon atoms. Examples of alkyl groups include ethyl, propyl, butyl, octyl, decyl, lauryl, cetyl (palmityl) and stearyl radicals.
[0054] In the context of the invention, the term “alkenyl” refers to a linear or branched aliphatic hydrocarbon chain which is unsaturated and contains one, two, three or more carbon-carbon double bonds. In particular, a C2-C52 alkenyl radical is a linear or branched aliphatic hydrocarbon chain containing one, two, three or more carbon-carbon double bonds and from 2 to 52 carbon atoms.
[0055] In the context of the invention, the term “alkynyl” refers to a linear or branched aliphatic hydrocarbon chain which is unsaturated and contains one, two, three or more carbon-carbon triple bonds. In particular, a C2-C52 alkynyl radical is a linear or branched aliphatic hydrocarbon chain containing one, two, three or more carbon-carbon triple bonds and from 2 to 52 carbon atoms.
[0056] In the context of the invention, the term “cyclic” refers to a stable cyclic radical containing three or more atoms. Examples of cyclic groups include phenyl, cyclopentyl and cyclohexyl.
[0057] In the context of the invention, the terms “heteroalkyl” or “heteroalkenyl” or “heteroalkynyl” refer respectively to “alkyl”, “alkenyl” or “alkynyl” groups containing at least one heteroatom, that is to say to linear or branched aliphatic hydrocarbon chains, saturated or unsaturated, containing at least one heteroatom, which may be the same or different, chosen from O, N or S, in which the sulfur atom(s) may optionally be oxidized. Examples include succinyl, adipoyl, sebacoyl, oleoyl, ricinolyl and linoleoyl radicals.
[0058] In the context of the invention, the term “heterocyclic” refers to a stable cyclic group containing two or more carbon atoms and at least one heteroatom, which may be the same or different, chosen from O, N or S, in which the sulfur atom(s) may optionally be oxidized. Examples of heterocyclic groups include furanyl, oxolanyl and thiophenyl radicals.
[0059] In one way, the process for preparing a polyester elastomer comprises the reaction of:(i) at least one dicarboxylic acid or tricarboxylic acid;(ii) at least one monocarboxylic acid; and(iii) at least one polyol.
[0060] According to a first embodiment, the preparation of the polyester elastomer is solvent-free and emollient-free. According to a second embodiment, the polyester elastomer is prepared with a solvent or an emollient as defined in the present document.
[0061] According to a particular embodiment of the invention, the polyester elastomer is composed only of polyester. According to a first preferred embodiment, the polyester elastomer is composed only of crosslinked polyester. According to a second preferred embodiment, the polyester elastomer is composed of crosslinked polyester and non-crosslinked polyester. According to a third preferred embodiment, the polyester elastomer is composed of polyester and solvent or emollient. According to a fourth preferred embodiment, the polyester elastomer is composed of crosslinked polyester and solvent or emollient. According to a fifth preferred embodiment, the polyester elastomer is composed of crosslinked polyester, non-crosslinked polyester and solvent or emollient.
[0062] According to a particular embodiment, the polyester elastomer is a powder.
[0063] According to another particular embodiment, the polyester elastomers form networks of crosslinked polymers. As the skilled person is well aware, these crosslinked polymers are not completely soluble and certain methods are available for characterizing them, particularly sol-gel analysis (determination of the gel fraction), swelling rate analysis (determination of the swelling ratio) and mechanical analysis (for example, determination of the modulus); see, for example, the publication Polym. Chem., 2024, 15, 219-247.
[0064] According to a preferred embodiment, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 20%. Preferably, the polyester elastomer fraction which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 40%. More preferably, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 50%. Even more preferably, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 60%. Better still, the fraction of the polyester elastomer which is not soluble in ethyl acetate (gel fraction) is greater than or equal to 70%.
[0065] The gelled fraction is appropriately defined as follows:
[0066] The gel fraction can be determined using an extraction method such as Soxhlet extraction.
[0067] According to a particular embodiment, the polyester elastomer composition is composed of polyester elastomer and of a solvent or emollient as defined in the present document. According to another particular embodiment, the polyester elastomer composition is composed of polyester elastomer without solvent or emollient as defined in the present document. In one way, the composition of the polyester elastomer is gel or powder.
[0068] According to a particular embodiment, the polyester elastomer composition is a polyester elastomer combined with one or more solvents or emollients, which can be converted into a polyester elastomer gel (the swollen polyester elastomer), for example, by applying a shear force to the composition.
[0069] A gel is a dispersed system comprising at least two components: a solid component and a liquid component. The solid component forms a three-dimensional spongelike network whose pores are filled with a liquid. The liquid component is thus immobilized in the solid. In the gel of the invention, the solid component is a three-dimensional network formed of the crosslinked polyester elastomer, and the liquid component is formed of one or more solvents or emollients as defined in the present application. A gel is a semi-solid that can have properties ranging from soft and fragile to hard and resistant. Gels are also defined as a considerably diluted crosslinked system.
[0070] An elastomer gel is thus made from elastomer powders or particles swollen or dispersed in a liquid, such as a solvent or emollient, to form a gel. The swelling capacity is generally expressed by the swelling rate of the polymer.Polyester elastomers
[0071] The present disclosure relates to an elastomer comprising the reaction product of:(i) at least one dicarboxylic acid or tricarboxylic acid;(ii) at least one monocarboxylic acid; and(iii) at least one polyol.
[0072] In one way, the elastomer is a polyester elastomer. According to a particular embodiment, the elastomer is a crosslinked polyester elastomer.
[0073] According to a particular embodiment, at least one of the components (i) and / or (iii) has a functionality > 2.
[0074] According to another particular embodiment, the polyol (iii) has a functionality ≥ 3.
[0075] According to another particular embodiment, the component (i) has a functionality of 2 (dicarboxylic acid) and the polyol (iii) has a functionality of ≥ 3.
[0076] A. Components of the elastomer
[0077] 1. Di-carboxylic acids
[0078] According to a particular embodiment, the dicarboxylic acid or acids used to prepare the elastomer are chosen from compounds of formula (IA): in which:R1A is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group.
[0079] According to a preferred embodiment, the dicarboxylic acid is a compound of formula (IA) in which R1A is a C4-C34 alkyl group, a C4-C34 heteroalkyl group, a C4-C34 alkenyl group, a C4-C34 heteroalkenyl group, a C4-C34 cyclic group or a C4-C34 heterocyclic group.
[0080] Preferably, the dicarboxylic acid is a compound of formula (IA) in which R1A is a C4-C34 alkyl group.
[0081] Preferably, the dicarboxylic acid is selected from the group consisting of succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, brassylic acid, dodecanedioic acid, dilinoleic acid, a C21 acid dimer, a C36 acid dimer, maleic acid, fumaric acid, traumatic acid and combinations thereof. According to one preferred embodiment, the dicarboxylic acid is dilinoleic acid. According to another preferred embodiment, the dicarboxylic acid is a C36 dimer acid. According to another preferred embodiment, the dicarboxylic acid is a hydrogenated C36 dimer.
[0082] According to a particular embodiment, the dicarboxylic acid is biobased or naturally derived.
[0083] 2. Tri-carboxylic acids
[0084] According to a particular embodiment, the tricarboxylic acid or acids used to prepare the elastomer are chosen from the compounds of formula (IB): in which:R1B is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group.
[0085] According to a preferred embodiment, the tricarboxylic acid is a compound of formula (IB) in which R1B is a C4-C34 alkyl group, a C4-C34 heteroalkyl group, a C4-C34 alkenyl group, a C4-C34 heteroalkenyl group, a C4-C34 cyclic group or a C4-C34 heterocyclic group.
[0086] Preferably, the tricarboxylic acid is a compound of formula (IB) in which R1B is a C4-C34 alkyl group.
[0087] Preferably, the tricarboxylic acid is selected from the group consisting of citric acid, a C54 acid trimer and a hydrogenated C54 acid trimer. According to a preferred embodiment, the tricarboxylic acid is a C54 acid trimer.
[0088] According to a particular embodiment, the tricarboxylic acid is biobased or naturally derived.
[0089] 3. Mono-carboxylic acids
[0090] According to a particular embodiment, the monocarboxylic acid or acids used to prepare the elastomer are chosen from the compounds of formula (II): in which:R2 is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group.
[0091] According to a preferred embodiment, the monocarboxylic acid is a compound of formula (II) in which R2 is a C5-C21 alkyl group, a C5-C21 heteroalkyl group, a C5-C21 alkenyl group, a C5-C21 heteroalkenyl group, a C5-C21 cyclic group or a C5-C21 heterocyclic group.
[0092] Preferably, the monocarboxylic acid is selected from the group consisting of caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid, behenic acid, oleic acid, linolenic acid and combinations thereof. According to a preferred embodiment, the monocarboxylic acid is oleic acid. According to another preferred embodiment, the monocarboxylic acid is isostearic acid.
[0093] According to a particular embodiment, the monocarboxylic acid is biobased or naturally derived.
[0094] 4. Polyols
[0095] According to a particular embodiment, the polyol or polyols used to prepare the elastomer are chosen from the compounds of formula (III): in which:R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group, a C3-C50 heteroalkenyl group, a C3-C50 cyclic group or a C3-C50 heterocyclic group; andn is an integer between 2 and 10.
[0096] According to a preferred embodiment, the polyol is a compound of formula (III) in which R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group or a C3-C50 heteroalkenyl group; and n is an integer from 2 to 10.
[0097] Preferably, the polyol is a compound of formula (III) in which R3 is a C3-C20 alkyl group, a C3-C20 heteroalkyl group, a C3-C20 alkenyl group or a C3-C20 heteroalkenyl group; and n is an integer from 2 to 10.
[0098] According to a preferred embodiment, the polyol is a compound of formula (III) in which n is an integer from 2 to 6. In particular, the polyol is a compound of formula (III) where n is 2, 3, 4, 5 or 6. According to another preferred embodiment, the polyol is a compound of formula (III) in which n is an integer from 3 to 10. Preferably, the polyol is a compound of formula (III) in which n is an integer from 3 to 6.
[0099] Preferably, the polyol is selected from the group consisting of glycerol, diglycerol, polyglycerol, polyglycerol-3, sorbitol, castor oil, hydrogenated castor oil, sugar alcohol, monosaccharide, disaccharides, oligosaccharides, polysaccharides, tannin, gallic acid, 1,2-propanediol, 1,3-propanediol, 1,4-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,5-hexanediol, 1,5-hexanediol, 1,6-hexanediol, hydrogenated C36 dimer diol, and combinations thereof. In one way, the polyol is hydrogenated castor oil. According to a preferred embodiment, the polyol is diglycerol. According to another preferred embodiment, the polyol is polyglycerol-3. According to another preferred embodiment, the polyol is polyglycerol-4.
[0100] According to a particular embodiment, the polyol is biobased or naturally derived.
[0101] B. Ratio of elastomer components
[0102] According to a particular embodiment, the elastomer comprises a defined molar ratio of carboxyl functional groups (-COOH) of the monocarboxylic acid to hydroxyl functional groups (-OH) of the polyol. It has been found that the molar ratio of carboxyl functional groups (-COOH) of the monocarboxylic acid to hydroxyl functional groups (-OH) of the polyol influences the performance of the polyester elastomer and the performance of the gel manufactured from the polyester elastomer.
[0103] In a preferred embodiment, the molar ratio of carboxyl functional groups (-COOH) of the monocarboxylic acid to hydroxyl functional groups (-OH) of the polyol is from about 1:2 to about 1:16. Preferably, the molar ratio of carboxyl functional groups (-COOH) of the monocarboxylic acid to hydroxyl functional groups (-OH) of the polyol is from about 1:2 to about 1:14. Preferably, the molar ratio of the carboxyl functional groups (-COOH) of the monocarboxylic acid to the hydroxyl functional groups (-OH) of the polyol is from about 1:2 to about 1:10. More preferably, the molar ratio of the carboxyl functional groups (-COOH) of the monocarboxylic acid to the hydroxyl functional groups (-OH) of the polyol is from about 1:2 to about 1:8. Even more preferably, the molar ratio of the carboxyl functional groups (-COOH) of the monocarboxylic acid to the hydroxyl functional groups (-OH) of the polyol is from about 1:2 to about 1:5. In particular, the molar ratio of carboxyl functional groups (-COOH) of the monocarboxylic acid to hydroxyl functional groups (-OH) of the polyol may be about 1:16, about 1:15, about 1:14, about 1:13, about 1:12, about 1:11, about 1:10, about 1:9, about 1:8, about 1:7, about 1:6, about 1:5, about 1:4, about 1:3 or about 1:2.
[0104] According to a preferred embodiment, the molar ratio of carboxyl functional groups (-COOH) of the dicarboxylic acid or tricarboxylic acid to hydroxyl functional groups (-OH) of the polyol is from about 1.5:1 to about 1:4. Preferably, the ratio of carboxyl functional groups (COOH) of the dicarboxylic acid or tricarboxylic acid to hydroxyl functional groups (OH) of the polyol is from about 1.5:1 to about 1:2. Preferably, the ratio between the carboxyl functional groups (-COOH) of the di-carboxylic acid or of the tri-carboxylic acid and the hydroxyl functional groups (-OH) of the polyol is from about 1.5:1 to about 1:1.5. More preferably, the ratio between the carboxyl functional groups (-COOH) of the di-carboxylic acid or of the tri-carboxylic acid and the hydroxyl functional groups (-OH) of the polyol is from about 1.5:1 to about 1:1.25. In particular, the ratio of carboxyl functional groups (-COOH) of the di-carboxylic acid or tri-carboxylic acid to hydroxyl functional groups (-OH) of the polyol may be about 1.5:4, about 1.5:3, about 1.5:2, about 1:1, about 1:2, about 1:3 or about 1:4.
[0105] If the molar ratio of dicarboxylic acid or tricarboxylic acid to polyol is kept constant, the amount of monocarboxylic acid has a substantial impact on the weight percentage of crosslinked polyester in the resulting polyester elastomer, and on the swell value (i.e. degree of swelling) of the polyester elastomer in the solvent, particularly the coco-caprylate / caprate. The swelling value of the polyester elastomer is an important indication of the performance of the polyester elastomer in cosmetic or dermatological formulations.
[0106] According to a particular embodiment, the conversion of the carboxylic acid functional groups (-COOH) to ester functional groups (-CO(O)-) is not less than 80% per mole. The percentage conversion is calculated by titration of the functional groups of the carboxylic acid (-COOH) with 0.1 N KOH in isopropanol.Emollient or solvent
[0107] The preparation of the polyester elastomer may take place in the presence of a solvent. The solvent may also act as an emollient, preferably a cosmetic emollient. When the solvent also acts as an emollient, it also provides a softening, protective, moisturizing and / or lubricating effect to the skin. According to a particular embodiment, the solvent or emollient is biobased or of natural origin. In a preferred embodiment, the solvent or emollient is a triglyceride solvent, a mono-ester solvent, a di-ester solvent, a citrate ester solvent, an ether solvent, a carbonatic solvent, a hydrocarbon solvent, or a combination thereof.
[0108] According to a particular embodiment, the solvent is a triglyceride solvent of formula (IV): in which:R4, R5 and R6 independently of one another represent a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group.
[0109] According to a preferred embodiment, the solvent is of formula (IV) in which R4, R5 and R6 independently of one another represent a C2-C17 alkyl group or a C2-C17 alkenyl group.
[0110] According to a particularly preferred embodiment, the solvent is a triglyceride solvent selected from the group consisting of caprylic / capric triglyceride, triheptanoin, corn oil, soybean oil, olive oil, rapeseed oil, cottonseed oil, coconut oil, almond oil, argan oil, rosehip oil, black seed oil, grape seed oil, avocado oil, apricot kernel oil, geranium oil, lavender oil, eglantine oil, macadamia oil, eucalyptus oil, safflower oil, linseed oil, sunflower oil, olive oil, canola oil, sesame oil, cottonseed oil, palm oil, rapeseed oil, abrasive oil, peanut oil, cuphea oil, milkweed oil, salicorn oil, castor oil and combinations thereof. In a way, the triglyceride solvent is selected from the group consisting of caprylic / capric triglyceride, triheptanoin, and combinations thereof.
[0111] According to a particular embodiment, the solvent is a mono-ester solvent of formula (V): in which:R7 is a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; andR8 is a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group.
[0112] According to a preferred embodiment, the solvent is a monoester solvent of formula (V) in which R7 is a C5-C17 alkyl group or a C5-C17 alkenyl group, and R8 is a C2-C17 alkyl group or a C2-C17 alkenyl group.
[0113] Preferably, the solvent is a monoester solvent selected from the group consisting of coco-caprylate, coco-caprate, jojoba oil, jojoba esters, isopropyl jojobate, ethyl macadamiate, isoamyl laurate, heptyl undecylenate, isostearyl isostearate, glyceryl ricinoleate, isostearyl palmitate, myristyl myristate, octyldodecyl myristate, octyldodecyl hydroxystearate, butyl myristate, ethylhexyl cocoate, ethylhexyl palmitate, ethylhexyl stearate, butyl stearate, decyl oleate, isocetyl behenate, isocetyl myristate, isocetyl palmitate, isocetyl stearate, isodecyl oleate, isopropyl isostearate, isopropyl myristate, isopropyl palmitate, oleyl oleate, propylene glycol laurate, octyldodecyl erucate, C12-C13 alkyl lactate, C12-C15 alkyl lactate, isostearyl lactate, glycereth-5-lactate, lauryl lactate, myristyl lactate, oleyl lactate, laureth-2 benzoate, C12-C15 alkyl benzoate, pareth-3-benzoate, dipropylene glycol benzoate, isodecyl salicylate, C12-C15 alkyl salicylate, tridecyl salicylate, ethylhexyl isononanoate, cetyl hexanoate, isononyl isononanoate, ethyl hexanoate, isodecyl isononanoate, tridecyl isononanoate, isotridecyl isononanoate, isostearyl isononanoate, cetearyl isononanoate, laureth-2-ethylhexanoate, cetearyl ethylhexanoate, isodecyl neopentanoate, isostearyl neopentanoate, octyldodecyl neopentanoate, tridecyl neopentanoate, and combinations thereof. More preferably, the monoester solvent is selected from the group consisting of coco-caprylate / caprate, coco-caprylate, jojoba oil, isoamyl laurate, methylheptyl isostearate, C12-C13 alkyl lactate, C12-C15 alkyl lactate, lauryl lactate, ethylhexyl isononanoate, cetyl hexanoate, isononyl isononanoate, isodecyl ethyl hexanoate, isodecyl isononanoate, isodecyl hexanoate ethylhexanoate, tridecyl isodecyl hexanoate, isostearyl isononanoate, cetearyl isononanoate, and combinations thereof. Preferably, the monoester solvent is selected from the group consisting of coco-caprylate / caprate, coco-caprylate, isoamyl laurate, isononyl isononanoate, heptyl undecylenate, jojoba oil, jojoba esters and combinations thereof.
[0114] According to a particular embodiment, the solvent is:a) a diester solvent of formula (VI): in which:R9 is a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; andR10 and R11 independently of one another represent a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; orb) a diester solvent of formula (VII): in which:R9 is a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; andR10 and R11 independently of one another represent a hydrogen atom, a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; orc) a diester solvent of formula (VIII): in which:R9 and R10 independently of one another represent a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group; andR11 is a hydrogen atom, a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group.
[0115] According to a preferred embodiment, the solvent is a di-ester solvent of formula (VI), formula (VII) or formula (VIII), where R11 is a C2-C10 alkyl group or a C2-C10 alkenyl group, and R9 and R10 independently of one another represent a C1-C12 alkyl group or a C2-C12 alkenyl group.
[0116] Preferably, the diester solvent is selected from the group consisting of diethyl succinate, dibutyl succinate, diethylhexyl succinate, diisopropyl sebacate, dimethyl sebacate, diethyl sebacate, dibutyl sebacate, diisostearyl dimer, isostearyl stealate, isostearyl stearate, isocetyl stearate, octyldodecyl stearate, diethylhexyl malate, dipropylene glycol dibenzoate, dicapryl adipate, dicaprylyl maleate, diisopropyl dimer, diisopropyl adipate, diisobutyl adipate, diisopropyl sebacate, diisostearyl dimer, diethylhexyl succinate, diethylene glycol diethylhexanoate, neopentyl glycol dicaprate, propylene glycol dicaprylate / dicaprate, neopentyl glycol diisostearate, neopentyl glycol diethylhexanoate, neopentyl glycol diheptanoate, and combinations thereof. In one way, the di-ester solvent is selected from the group consisting of dicapryl adipate, dicaprylyl maleate, diisopropyl adipate, diisobutyl adipate, diethyl succinate, dibutyl succinate, diethylhexyl succinate, diisopropyl sebacate, dimethyl sebacate, diethyl sebacate, dibutyl sebacate, diethyl glycol diethylhexanoate, neopentyl glycol diheptanoate, and combinations thereof.
[0117] According to a particular embodiment, the solvent is a citrate ester solvent of formula (IX): in which:R12, R13, R14 and R15 independently of one another represent a hydrogen atom, a C1-C35 alkyl group, a C1-C35 heteroalkyl group, a C2-C35 alkenyl group or a C2-C35 heteroalkenyl group, at least one of R12, R13, R14 and R15 not being a hydrogen atom.
[0118] According to a preferred embodiment, the solvent is a citrate ester solvent of formula (IX) in which R12, R13 and R14 independently of one another represent a C1-C10 alkyl group or a C2-C10 alkenyl group, and R15 is an acetyl group.
[0119] Preferably, the solvent is a citrate ester solvent selected from the group consisting of tricaprylyl citrate, triisostearyl citrate, triisocetyl citrate, trioctyldodecyl citrate, triethyl citrate, tributyl citrate, triethyl acetyl citrate, tributyl acetyl citrate, trioctyldodecyl citrate, triisocetyl citrate and combinations thereof.
[0120] According to a particular embodiment, the solvent is an ether solvent of formula (X): in which:R16 and R17 independently of one another represent a hydrogen atom, a C2-C20 alkyl group, a C2-C20 heteroalkyl group, a C2-C20 alkenyl group or a C2-C20 heteroalkenyl group, at least one of the groups R16 and R17 not being a hydrogen atom.
[0121] According to a preferred embodiment, the solvent is an ether solvent of formula (X) in which R16 and R17 independently of one another represent a C2-C20 alkyl group.
[0122] Preferably, the solvent is an ether solvent selected from the group consisting of dicaprylyl ether, didecyl ether, panthenyl ethyl ether, dicetyl ether, dimyristyl ether, distearyl ether, dilauryl ether, and combinations thereof. More preferably, the ether solvent is selected from the group consisting of dicaprylyl ether, didecyl ether and combinations thereof.
[0123] According to a particular embodiment, the solvent is a carbonatic solvent of formula (XI): in which:R18 and R19 independently of one another represent a hydrogen atom, a C2-C20 alkyl group, a C2-C20 heteroalkyl group, a C2-C20 alkenyl group or a C2-C20 heteroalkenyl group.
[0124] According to a preferred embodiment, the solvent is a carbonatic solvent of formula (XI) in which R18 and R19 independently of one another represent a C2-C20 alkyl group.
[0125] Preferably, the solvent is a carbonatic solvent selected from the group consisting of dicaprylyl carbonate, diethylhexyl carbonate and combinations thereof.
[0126] According to a particular embodiment, the solvent is a hydrocarbon whose number of carbon atoms is between C4 and C60. According to a preferred embodiment, the solvent is a hydrocarbon with a number of carbon atoms of between C10 and C50. Preferably, the solvent is a hydrocarbon with a number of carbon atoms of C20 to C40.
[0127] Preferably, the solvent is a hydrocarbon solvent selected from the group consisting of farnesene, hydrogenated farnesene, coconut alkanes, coconut / palm kernel alkanes, C9-C12 alkanes, C10-C13 alkanes, C12-C17 alkanes, C13-C14 alkanes, C14-C17 alkanes, C14-C19 alkanes, C14-C20 alkanes, C14-C22 alkanes, C15-C19 alkanes, C21-C28 alkanes, C17-C23 alkanes, C9-C12 isoalkanes, C9-C13 isoalkanes, C9-C14 isoalkanes, C9-C16 isoalkanes, C10-C11 isoalkane, C10-C12 isoalkane, C10-C13 isoalkane, C11-C12 isoalkane, C11-C13 isoalkane, C11-C14 isoalkane, C12-C14 isoalkane, C12-C15 isoalkane, C12-C20 isoalkane, C13-C14 isoalkane, C13-C16 isoalkane, C14-C16 isoalkane, C15-C19 isoalkane, C10-C16 olefin, C12-C18 olefin, C18-C26 olefin, C20 olefin, C20-C24 olefin, C24-C30 olefin, C26-C28 olefin, C26-C54 olefin, C28-C36 olefin, C28-C52 olefin, C30-C38 olefin, C30-C45 olefin, C4-C12 olefin, C4-C6 olefin, C5-C6 olefin, poly(C6 / C10 / C14 olefin), poly(C6-C12 olefin), poly(C6-C12 olefin), poly(C6-C14 olefin), poly(C6-C20 olefin), poly(C8 / C12 olefin), poly(C20-C28 olefin), poly(C30-C45 olefin), poly(C4-C12 olefin), poly(C6-C14 olefin), hexadecene, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, diethylhexylcyclohexane, undecane, tridecane, tetradecane, pentadecane, hexadecane, octadecane, docosane, squalane, hydrogenated polyisobutene, polybutene, hydrogenated polydecene, hydrogenated didecene, mineral oil, petroleum jelly, dodecane, isohexadecane, isododecane, isoeicosan and combinations thereof. From a point of view, the hydrocarbon solvent is selected from the group consisting of squalane, farnesene, hydrogenated farnesene, coconut alkanes, C9-C12 alkane, C13-C15 alkane, C14-C19 alkane, C14-C20 alkane, C14-C22 alkane, C15-C19 alkane, C13-C16 isoalkane, dodecane, decane, tridecane, tetradecane, pentadecane, hexadecene, octadecane, squalane, isododecane, isohexadecane, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, and combinations thereof. On the one hand, the hydrocarbon solvent is selected from the group consisting of squalane, hydrogenated farnesene, coconut alkanes, C9-C12 alkane, C13-C15 alkane, C13-C16 isoalkane, C14-C19 alkane, dodecane, tetradecane, isododecane, hexadecane, octadecane, hexadecene, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane, and combinations thereof.
[0128] More preferably, the hydrocarbon solvent is selected from the group consisting of squalane, C32 alkane, C32 isoalkane, C54 alkane, C54 isoalkane and combinations thereof.
[0129] According to a particular embodiment, a defined amount of solvent is used in the preparation of the polyester elastomer. According to a preferred embodiment, the amount of solvent is from 0% to 70% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C). Preferably, the amount of solvent is from 0% to 50% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C). Preferably, the amount of solvent is from 0% to 40% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C). More preferably, the amount of solvent is from 0% to 30% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C). Even more preferably, the solvent range is from 0% to 20% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C).
[0130] According to a particular embodiment, the amount of solvent is from 10% to 50% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), of the mono-carboxylic acid (B) and of the polyol (C). In particular, the amount of solvent may be 50%, 40%, 30%, 20% or 10% of the total weight of the di-carboxylic acid or tri-carboxylic acid (A), the mono-carboxylic acid (B) and the polyol (C).
[0131] According to a particular embodiment, the amount of solvent is from 0% to 30% of the total weight of the dicarboxylic acid or of the tricarboxylic acid (A) and of the monocarboxylic acid (B). According to a preferred embodiment, the amount of solvent is from 0% to 20% of the total weight of the di-carboxylic acid or of the tri-carboxylic acid (A) and of the mono-carboxylic acid (B). Preferably, the amount of solvent is from 0% to 10% of the total weight of the di-carboxylic acid or the tri-carboxylic acid (A) and the mono-carboxylic acid (B). According to another preferred embodiment, the amount of solvent is from 10% to 30% of the total weight of the di-carboxylic acid or of the tri-carboxylic acid (A) and of the mono-carboxylic acid (B). In particular, the solvent may represent 30%, 20% or 10% of the total weight of the dicarboxylic acid or of the tricarboxylic acid (A) and of the monocarboxylic acid (B).
[0132] According to a particular embodiment, no solvent is used to prepare the elastomer.
[0133] According to another particular embodiment, a solvent is used to prepare the polyester elastomer and is removed after the polyester elastomer is prepared, to form a polyester elastomer powder. In one way, to the polyester elastomer powder, a solvent / emollient can be added again to form a polyester elastomer gel, with optional application of a shear force as described below.
[0134] According to a particular embodiment, the polyester elastomer is made from C36 dimer acid, diglycerol and isostearic acid with about 10% to about 40% by weight of squalane based on the total weight of the polyester elastomer and squalane. That is, from a certain point of view, the invention relates to a polyester elastomer composition made from C36 dimer acid, diglycerol, isostearic acid and squalane, comprising about 10% to about 40% by weight of squalane.
[0135] According to a particular embodiment, the polyester elastomer is made from hydrogenated C36 dimer acid, diglycerol and oleic acid without any solvent or emollient.
[0136] In a preferred embodiment, the elastomer used according to the invention, of the INCI name COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE copolymer (and) SQUALANE, is available from the company Momentive under the name Harmonie NatuVel Gel™.Hydrophobic silica particles
[0137] The composition according to the invention comprises hydrophobic silica particles.
[0138] In the context of the invention, the hydrophobic silica particles can be characterised by the water wettability test described below.
[0139] The hydrophobicity test is carried out following the procedure below:Introduce 50 mL of demineralised water (at room temperature) into a 100 mL beaker ;Sprinkle approximately 0.1 g of the silica to be analysed onto the surface of the water;Briefly swirl the beaker by hand;Wait 10 minutes before observing the result.
[0140] The silica particles are considered hydrophobic if they meet all of the following observations:The powder floats on the surface;The solution remains clear;The solution does not show any visible particles;The solution does not become coloured.
[0141] Thus, examples of hydrophobic silica particles within the meaning of the invention include silica particles with the INCI name SILICA DIMETHYL SILYLATE, such as that marketed under the name AEROSIL R 972 by the company EVONIK, and silica particles with the INCI name SILICA SILYLATE, such as those marketed under the name DOW CORNING VM-2270 AEROGEL FINE PARTICLES by the company DOW, under the name AIRLICA TL-10 by the company TOKUYAMA CORPORATION, or under the name CAB-O-SIL TS-530 by the company CABOT.
[0142] Conversely, an example of non-hydrophobic silica particles within the meaning of the invention includes silica with the INCI name SILICA, such as that marketed under the name HARMONIE LUXE 4 POWDER by the company MOMENTIVE PERFORMANCE MATERIALS.
[0143] According to a particular embodiment of the invention, these particles may be in the form of aggregates.
[0144] According to the invention, the term “aggregates” is understood to mean an assembly of distinct compounds which adhere to each other and form a whole. Such aggregates can have various shapes and sizes.
[0145] In particular, the hydrophobic silica particles are chosen from hydrophobic silica aerogel particles, and are preferably chosen from hydrophobic silica aerogel particles surface-modified with alkyl and / or trimethylsilyl groups.
[0146] The term “hydrophobic silica” means both pure hydrophobic silicas and particles completely or partially coated with hydrophobic silica.
[0147] Hydrophobic silicas that may be used are preferably amorphous and of fumed origin. They are preferably provided in pulverulent form.
[0148] The amorphous hydrophobic silicas of fumed origin are generally obtained from hydrophilic fumed silicas. The latter are obtained by pyrolysis of silicon tetrachloride (SiCl4) in a continuous flame at 1000°C in the presence of hydrogen and oxygen. They are subsequently rendered hydrophobic for example by treatment with halogenated silanes, alkoxysilanes or silazanes. The hydrophobic silicas differ from the starting hydrophilic silicas, inter alia, by a lower density of silanol groups and by a smaller adsorption of water vapor.
[0149] In particular, a composition according to the invention may comprise a fumed silica.
[0150] Fumed silica which has undergone a hydrophobic surface treatment is very particularly suitable for the invention. It is indeed possible to chemically modify the surface of the silica, by chemical reaction generating a reduction in the number of silanol groups present at the surface of the silica. It is possible in particular to substitute silanol groups with hydrophobic groups: a hydrophobic silica is then obtained.
[0151] The hydrophobic groups may be:- trimethylsiloxyl groups, which are obtained in particular by treatment of fumed silica in the presence of hexamethyldisilazane. Silicas thus treated are known as “Silica Silylate” according to the CTFA (8th edition, 2000). They are sold, for example, under the references Aerosil R812® by Degussa and Cab-O-Sil TS-530® by Cabot.
[0152] - hydrophobic groups may especially be dimethylsilyloxyl groups, which are especially obtained by treating fumed silica in the presence of dimethyldichlorosilane. Silicas thus treated are known as “Silica Dimethyl Silylate” according to the CTFA (6th edition, 1995). They are sold, for example, under the references Aerosil R972®and Aerosil R974®by Degussa and Cab-O-Sil TS-610®and Cab-O-Sil TS-720®by Cabot.
[0153] More particularly, mention will be made of hydrophobic silica aerogel particles (INCI name: Silica silylate), such as those sold by the company Dow Corning under the name Dow Corning VM-2270 Aerogel Fine Particles, and those sold by the company Tokuyama Corporation under the name AirLica TL-10.
[0154] In particular, the composition according to the invention comprises from 0.1% to 10% by weight, preferably from 0.5% to 10% by weight, and more preferentially from 1% to 8% by weight, better still from 1.5% to 7% by weight, and even better still from 2% to 5% by weight of hydrophobic silica particles, and more particularly of hydrophobic silica aerogel particles, relative to the total weight of the composition.UV screening agents
[0155] According to a particular embodiment, the composition in accordance with the invention comprises at least one UV screening agent. The UV screening agent(s) can be chosen from organic UV screening agents and inorganic UV screening agents.
[0156] The UV screening agent(s) can be chosen from lipophilic organic UV screening agents and hydrophilic organic UV screening agents.
[0157] According to a preferred embodiment, the composition according to the invention comprises at least one UV screening agent chosen from lipophilic organic UV screening agents and inorganic UV screening agents. The composition in accordance with the invention preferably comprises at least one lipophilic organic UV screening agent.Lipophilic organic UV screening agents
[0158] A “lipophilic organic UV screening agent” means any organic UV screening agent capable of being completely dissolved in molecular form in a liquid fatty phase or else capable of being dissolved in colloidal form (for example in micellar form) in a liquid fatty phase.
[0159] The lipophilic organic screening agents are notably chosen from cinnamic compounds; anthranilate compounds; salicylic compounds; dibenzoylmethane compounds; benzylidene camphor compounds; benzophenone compounds; β,β-diphenylacrylate compounds; triazine compounds; benzotriazole compounds; benzalmalonate compounds, notably those cited in patent US 5 624 663; benzimidazole derivatives; imidazoline compounds; bis-benzazolyl compounds, as described in patents EP 669 323 and US 2 463 264; methylene bis(hydroxyphenylbenzotriazole) compounds, as described in patent applications US 5 237 071, US 5 166 355, GB 2 303 549, DE 197 26 184 and EP 893 119; benzoxazole compounds, as described in patent applications EP 0 832 642, EP 1 027 883, EP 1 300 137 and DE 101 62 844; screening polymers and screening silicones, such as those described notably in patent application WO 93 / 04665; dimeric α-alkylstyrene derivatives, such as those described in patent application DE 198 55 649; 4,4-diarylbutadiene compounds, as described in patent applications EP 0 967 200, DE 197 46 654, DE 197 55 649, EP-A-1 008 586, EP 1 133 980 and EP 133 981, and mixtures thereof.
[0160] Preferably, the lipophilic organic screening agent(s) are chosen from salicylic compounds, dibenzoylmethane compounds, benzylidene camphor compounds; benzophenone compounds; triazine compounds; benzotriazole compounds; and mixtures thereof.
[0161] As examples of lipophilic organic photoprotective agents, mention may be made of those denoted hereinbelow under their INCI name and / or their chemical name.
[0162] Cinnamic compounds:Ethylhexyl methoxycinnamate sold in particular under the trade name PARSOL® MCX by DSM Nutritional Products;isoamyl p-methoxycinnamate sold under the trade name NEO HELIOPAN E 1000® by Symrise,
[0163] Dibenzoylmethane compounds:Butylmethoxydibenzoylmethane notably sold under the trade name Parsol® 1789 by the company DSM Nutritional Products,
[0164] Salicylic compounds:Homosalate sold under the name Parsol® HMS by DSM Nutritional Products,ethylhexyl salicylate sold under the name NEO HELIOPAN® OS by Symrise,
[0165] β,β-Diphenylacrylate compounds:Octocrylene, notably sold under the trade name Uvinul® N 539 T by the company BASF,
[0166] Benzophenone compounds:Benzophenone-3 or oxybenzone, sold under the trade name UVINUL® M 40 by the company BASF,diethylamino hydroxybenzoyl hexyl benzoate sold under the trade name UVINUL® A Plus or as a mixture with ethylhexyl methoxycinnamate, under the trade name Uvinul® A Plus B, by the company BASF,
[0167] Benzylidene camphor compounds:4-Methylbenzylidene camphor, sold under the name Eusolex® 6300 by the company Merck,
[0168] Phenylbenzotriazole compounds:Drometrizole trisiloxane manufactured under the name Mexoryl® XL by the company Noveal,
[0169] Methylenebis(hydroxyphenylbenzotriazole) compounds:Methylenebis(benzotriazolyl)tetramethylbutylphenol notably in solid form, such as the product sold under the trade name Mixxim BB / 100® by the company Fairmount Chemical,
[0170] Triazine compounds:- 3,3’-(1,4-Phenylene)bis(5,6-diphenyl-1,2,4-triazine), having the INCI name Phenylene Bis-Diphenyl Triazine,- bis-Ethylhexyloxyphenol methoxyphenyl triazine sold under the trade name Tinosorb® S by the company BASF,- Ethylhexyl triazone, notably sold under the trade name Uvinul® T150 by the company BASF,- Diethylhexyl butamido triazone sold under the trade name Uvasorb® HEB by the company 3V Sigma,- the symmetrical triazine screening agents substituted with naphthalenyl groups or polyphenyl groups, described in patent US 6 225 467, patent application WO 2004 / 085412 (see compounds 6 and 9) or the document “Symmetrical Triazine Derivatives” IP.COM IPCOM000031257 Journal, INC West Henrietta, NY, US (September 20, 2004),
[0171] Anthranilic compounds:Menthyl anthranilate sold under the trade name Neo Heliopan® MA by the company Symrise,
[0172] Benzalmalonate compounds:Polyorganosiloxane bearing benzalmalonate functions, such as Polysilicone-15, sold under the trade name Parsol SLX® by the company Hoffmann-LaRoche.Hydrophilic organic UV screening agents
[0173] For the purposes of the present invention, the term “hydrophilic organic UV screening agent” means a water-soluble organic UV screening agent or a water-dispersible organic UV screening agent.
[0174] The term “water-soluble organic screening agent” means any organic screening agent that can be fully dissolved in molecular form in a liquid aqueous phase or that can be dissolved in colloidal form (for example in micellar form) in a liquid aqueous phase.
[0175] The term “water-dispersible organic screening agent” means any organic screening agent that is capable of forming, in a liquid aqueous phase, a homogeneous suspension of particles with a volume-mean size of less than 100 microns. The volume-average size is determined by laser diffraction particle size analysis.
[0176] Among the water-soluble organic UVA screening agents that may be used according to the present invention, mention may be made of benzene-1,4-bis(3-methylidene-10-camphorsulfonic) acid (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) and the various salts thereof, notably described in patent applications FR-A-2528420 and FR-A-2639347. Mention may notably be made of benzene-1,4-bis(3-methylidene-10-camphorsulfonic acid) (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) such as the product which is manufactured under the name Mexoryl® SX by the company Noveal.
[0177] These screening agents correspond to the general formula (I) below: in which F denotes a hydrogen atom, an alkali metal or a radical NH(R1)3+in which the radicals R1, which may be identical or different, denote a hydrogen atom, a C1to C4alkyl or hydroxyalkyl radical or a group Mn+, Mn+denoting a polyvalent metal cation in which n is equal to 2 or 3 or 4, Mn+preferably denoting a metal cation chosen from Ca2+, Zn2+, Mg2+, Ba2+, Al3+and Zr4+. It is clearly understood that the compounds of formula (I) above can give rise to the “cis-trans” isomer around one or more double bonds and that all the isomers fall within the context of the present invention.
[0178] Among the water-soluble organic UVA screening agents that may be used according to the present invention, mention may also be made of compounds including at least two benzazolyl groups bearing sulfonic groups, such as those described in patent application EP-A-0669323.
[0179] They are described and prepared according to the syntheses indicated in patent US 2,463,264 and also in patent application EP-A-0669323.
[0180] The compounds including at least two benzazolyl groups in accordance with the invention correspond to the general formula (II) below: (II),in which- Z represents an organic residue of valency (l + n) comprising one or more double bonds placed such that it completes the system of double bonds of at least two benzazolyl groups as defined inside the square brackets so as to form a totally conjugated assembly;- X’ denotes S, O or NR6;- R1denotes a hydrogen atom, a C1to C18alkyl, a C1to C4alkoxy, a C5to C15aryl, a C2to C18acyloxy, or a group SO3Y or COOY;- the radicals R2, R3, R4and R5, which are identical or different, denote a nitro group or a radical R1;- R6denotes a hydrogen atom, a C1to C4alkyl or a C1to C4hydroxyalkyl;- Y denotes a hydrogen atom, Li, Na, K, NH4, 1 / 2Ca, 1 / 2Mg, 1 / 3Al or a cation resulting from the neutralization of a free acid group with an organic nitrogen base;- m is 0 or 1;- n is a number from 2 to 6;- l is a number from 1 to 4;- with the proviso that l + n does not exceed the value 6.
[0181] Among these compounds, preference will very particularly be given to 1,4-bis(benzimidazolyl)phenylene-3,3’,5,5’-tetrasulfonic acid (INCI name: Disodium Phenyl Dibenzimidazole Tetrasulfonate) or a salt thereof, having the following structure, notably sold under the name Neo Heliopan® AP by the company Symrise:
[0182] Preferably, the water-soluble screening agent that is capable of absorbing UVA rays is benzene-1,4-di(3-methylidene-10-camphorsulfonic acid) (INCI name: Terephthalylidene Dicamphor Sulfonic Acid) such as the product which is manufactured under the name Mexoryl SX by Noveal.
[0183] The water-soluble organic UVB screening agents that may be used according to the present invention are notably chosen from water-soluble cinnamic derivatives, such as ferulic acid or 3-methoxy-4-hydroxycinnamic acid; water-soluble benzylidenecamphor compounds; water-soluble phenylbenzimidazole compounds; water-soluble p-aminobenzoic (PABA) compounds; water-soluble salicylic compounds, and mixtures thereof.
[0184] As examples of water-soluble organic UVB screening agents, mention may be made of phenylbenzimidazole compounds, such as 2-phenyl-1H-benzimidazole-5-sulfonic acid (INCI name: phenylbenzimidazole sulfonic acid) notably sold under the trade name Eusolex 232®by Merck.
[0185] The composition according to the invention may also comprise at least one mixed water-soluble screening agent that is capable of absorbing UVA and UVB rays.
[0186] When the water-soluble UV screening agent is of sulfonic acid type, it is preferably associated with an organic base, such as an alkanolamine.
[0187] The term “alkanolamine” means a C2-C10compound comprising at least one primary, secondary or tertiary amine function and at least one alcohol, generally primary alcohol, function. As suitable alkanolamines, mention may be made of 2-amino-2-(hydroxymethyl)-1,3-propanediol (INCI name: Tromethamine) and triethanolamine.
[0188] Among the water-dispersible organic screening agents, mention may be made of the following screening agents.
[0189] Benzophenone compounds:1,1’-(1,4-Piperazinediyl)bis[1-[2-[4-(diethylamino)-2-hydroxybenzoyl]phenyl]methanone] (CAS 919803-06-8), as described in patent application WO 2007 / 071584; this compound advantageously being used in micronized form (volume-mean size of 0.02 to 2 µm), which may be obtained, for example, according to the micronization process described in patent applications GB-A-2 303 549 and EP-A-893119, and notably in the form of an aqueous dispersion,
[0190] Methylenebis(hydroxyphenylbenzotriazole) compounds:Methylene bis(benzotriazolyl)tetramethylbutylphenolin the form of an aqueous dispersion of micronized particles with a volume-average particle size which ranges from 0.01 to 5 µm, more preferentially from 0.01 to 2 µm and more particularly from 0.020 to 2 µm, with at least one alkyl polyglycoside surfactant having the structure CnH2n+1O(C6H10O5)xH, in which n is an integer from 8 to 16 and x is the mean degree of polymerization of the (C6H10O5) unit and ranges from 1.4 to 1.6 such as the aqueous dispersions described in patent GB-A-2 303 549, in particular the product sold under the trade name Tinosorb® M by BASF, orin the form of an aqueous dispersion of micronized particles with a volume-average particle size which ranges from 0.02 to 2 µm, and more preferentially from 0.01 to 1.5 µm and more particularly from 0.02 to 1 µm, in the presence of at least one polyglyceryl mono(C8-C20)alkyl ester with a degree of glycerol polymerization of at least 5, such as the aqueous dispersions described in patent application WO 2009 / 063392, in particular the product sold under the name Tinosorb WPGL by BASF,
[0191] Triazine compounds:- bis(ethylhexyloxyphenol)methoxyphenyl triazine in its water-dispersible form, having the INCI name Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine (and) Acrylates / C12-22 Alkyl Methacrylate Copolymer, under the trade name Tinosorb® S LiteAqua by the company BASF,- symmetrical triazine screening agents substituted with naphthalenyl groups or polyphenyl groups used in micronized form (mean particle size of 0.02 to 3 µm) which may be obtained, for example, via the micronization process described in patent applications GB-A-2 303 549 and EP-A-893119, and notably in aqueous dispersion form, notably 2,4,6-tris(biphenyl)triazine and 2,4,6-tris(terphenyl)triazine sold under the name Tinosorb® A2B by the company BASF and included in patent applications WO 06 / 035000, WO 06 / 034982, WO 06 / 034991, WO 06 / 035007, WO 2006 / 034992 and WO 2006 / 034985,
[0192] Benzoxazole compounds:2-[4-(1,3-Benzoxazol-2-yl)phenyl]-1,3-benzoxazole, having the CAS number 904-39-2.
[0193] According to a particular embodiment of the invention, the composition comprises at least one UV screening agent chosen from lipophilic organic UV screening agents; preferably they are chosen from diethylamino hydroxybenzoyl hexyl benzoate (sold in particular under the trade name “Uvinul® A Plus” or mixed with ethylhexyl methoxycinnamate under the trade name “Uvinul® A Plus B” by the company BASF), Drometrizole Trisiloxane (in particular manufactured under the name “Mexoryl® XL” by the company Noveal), bis-ethylhexyloxyphenol methoxyphenyl triazine (in particular sold under the trade name “Tinosorb® S” by the company BASF), ethylhexyl triazone (sold in particular under the trade name “Uvinul® T 150” by the company BASF), butyl methoxydibenzoylmethane (sold in particular under the trade name “Parsol 1789 ®” by the company DSM Nutritional Products), octocrylene (sold in particular under the trade name “Uvinul® N 539 T” by the company BASF), ethylhexyl salicylate (sold in particular under the trade name “Neo Heliopan® OS” by the company Symrise), homosalate (in particular sold under the trade name “Parsol® HMS” by the company DSM Nutritional Products).
[0194] When present in the composition, the organic UV screening agent(s) are generally present in an amount greater than or equal to 0.2% by weight, preferably greater than or equal to 1% by weight relative to the total weight of the composition. According to a particular embodiment, the one or more UV screening agents are present in an amount of between 0.2% and 50% by weight, preferably between 0.5% and 40% by weight, preferentially between 0.8% and 35% by weight, more preferentially between 1% and 30% by weight, even more preferentially between 1.5% and 25% by weight, and better still between 2% and 20% by weight relative to the total weight of the composition.Inorganic UV screening agents
[0195] According to a particular embodiment of the invention, the composition comprises at least one inorganic UV screening agent.
[0196] The inorganic UV screening agents that may be used in accordance with the present invention are metal oxide pigments. More preferentially, the inorganic UV screening agents of the invention are metal oxide particles having an average elementary particle size of less than or equal to 0.5 µm, more preferentially of between 0.005 and 0.5 µm, and more preferentially still of between 0.01 and 0.2 µm, even better still between 0.01 and 0.1 µm, and more particularly between 0.015 and 0.05 µm. They are notably described in Annex VI, updated on 22 / 09 / 2021, of the European regulation on cosmetic products number 1223 / 2009, but are not limited to that list.
[0197] They may in particular be selected from titanium, zinc, iron, zirconium and cerium oxides, or mixtures thereof.
[0198] Such coated or uncoated metal oxide pigments are described in particular in patent application EP-A-0 518 773. Commercial pigments that may be mentioned include the products sold by the companies Croda, Tayca and Merck.
[0199] The metal oxide pigments may be coated or uncoated.
[0200] The coated pigments are pigments that have undergone one or more surface treatments of chemical, electronic, mechanochemical and / or mechanical nature with compounds such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids, metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.
[0201] The coated pigments are more particularly titanium oxides that have been coated:- with hydrated silica, such as the product MT-100WP from the company Tayca,- with silica and iron oxide, such as the product Sunveil F® from the company Ikeda,- with silica and alumina, such as the products MT 500 SA® and MT 100 SA® from the company Tayca, and Tioveil™ AQ-N from the company Croda,- with alumina, such as the product TTO-55 (A)® from the company Ishihara,- with alumina and aluminum stearate, such as the products MT 100 TV®, MT 100 Z® and MT-01® from the company Tayca, the product Solaveil™ CT100 from the company Croda and the product Eusolex T-AVO® from the company Merck,- with silica, alumina and alginic acid, such as the product MT-100 AQ® from the company Tayca,- with alumina and aluminum laurate,- with iron oxide and iron stearate,- with zinc oxide and zinc stearate,- with silica and alumina and treated with a silicone, such as the products MTY-500SAS® or Microtitanium Dioxide MT-100 SAS® from the company Tayca,- with silica, alumina, aluminum stearate and treated with a silicone,- with silica and treated with a silicone,- with alumina and treated with a silicone, such as the product TTO-55(S)® from the company Ishihara,- with triethanolamine,- with stearic acid, such as the product TTO-55 (C)® from the company Ishihara,- with sodium hexametaphosphate,- TiO2treated with octyl trimethyl silane,- TiO2treated with a polydimethylsiloxane,- anatase / rutile TiO2treated with a polydimethylhydrogenosiloxane,- TiO2coated with triethylhexanoin, aluminum stearate and alumina sold under the trade name Solaveil™ CT-200 by Croda,- TiO2coated with aluminum stearate, alumina and silicone sold under the trade name Solaveil™ CT-12W by Croda,- TiO2coated with lauroyl lysine,- TiO2coated with C9-C15 fluoro alcohol phosphate and aluminum hydroxide.
[0202] Mention may also be made of TiO2pigments doped with at least one transition metal such as iron, zinc or manganese and more particularly manganese. Preferably, said doped pigments are in the form of an oily dispersion. The oil present in the oily dispersion is preferably chosen from triglycerides including those of capric / caprylic acids. The oily dispersion of titanium oxide particles may also include one or more dispersants, for instance a sorbitan ester, for instance sorbitan isostearate, or a polyoxyalkylenated fatty acid ester of glycerol, for instance TRI-PPG3 myristyl ether citrate and polyglyceryl-3 polyricinoleate. Preferably, the oily dispersion of titanium oxide particles includes at least one dispersant chosen from polyoxyalkylenated fatty acid esters of glycerol. Mention may be made more particularly of the oily dispersion of TiO2particles doped with manganese in capric / caprylic acid triglyceride in the presence of TRI-PPG-3 myristyl ether citrate and polyglyceryl-3 polyricinoleate and sorbitan isostearate having the INCI name: titanium dioxide (and) TRI-PPG-3 myristyl ether citrate (and) polyglyceryl-3 ricinoleate (and) sorbitan isostearate, or the product sold under the trade name Optisol™ OTP-1 by the company Croda.
[0203] Uncoated titanium oxide pigments are sold, for example, by the company Tayca under the trade names MT-500B and MT-600B®, or by the company Evonik under the trade name Degussa P 25.
[0204] The uncoated zinc oxide pigments are, for example:- those sold under the name Z-Cote® by the company BASF;- those sold under the name NanoArc® Zinc Oxide by the company Nanophase Technologies.
[0205] The coated zinc oxide pigments are, for example:- ZnO coated with polymethylhydrosiloxane;- Solaveil™ CZ-100 from Croda, dispersed in C12-15 alkyl benzoate (INCI: Zinc Oxide (and) C12-15 Alkyl Benzoate (and) Polyhydroxystearic Acid (and) Isostearic Acid);- those sold under the name Daitopersion Zn-60VA® by the company Daito Kasei (dispersions in C9-12 alkane with a dispersant);- those sold under the name SPD-Z5® by the company Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane).
[0206] The uncoated cerium oxide pigments may be, for example, those sold under the name Rhodigard® W185 by the company Solvay.
[0207] Mention may also be made of mixtures of metal oxides, in particular of titanium dioxide and of cerium dioxide, including the equal-weight mixture of titanium dioxide and cerium dioxide coated with silica, and also the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone or coated with alumina, silica and glycerol.
[0208] When the composition in accordance with the invention comprises inorganic UV screening agents, coated or uncoated titanium oxide pigments are particularly preferred.
[0209] When present in the composition in accordance with the invention, the inorganic UV screening agent(s) generally are present in an amount of between 0.2% and 50% by weight, preferably between 0.3% and 30% by weight, preferentially between 0.5% and 25% by weight, more preferentially between 1% and 20% by weight, and better still between 2% and 10% by weight relative to the total weight of the composition.
[0210] According to a particular embodiment of the invention, the composition comprises less than 10% by weight, relative to the total weight of the composition, of inorganic screening agents. Preferably, the composition comprises less than 5% by weight, relative to the total weight of the composition, of inorganic screening agents.
[0211] According to another particular embodiment, the composition is free of inorganic screening agents.
[0212] For the purposes of the present invention, the expression “free of inorganic UV screening agents” is understood to mean an amount of inorganic UV screening agents of less than 2% by weight, preferably less than 1% by weight, and even more preferentially less than 0.5% by weight relative to the total weight of the composition.
[0213] According to a particular embodiment, the total amount of UV screening agents when present in the composition is greater than or equal to 0.1% by weight, preferably greater than or equal to 1.5% by weight, and even more preferentially greater than or equal to 10% by weight, preferably greater than or equal to 15% by weight of the total weight of the composition.
[0214] According to a preferred embodiment, the total amount of UV screening agents, when they are present in the composition, is between 0.2% and 50% by weight, preferably between 0.5% and 40% by weight, preferentially between 0.8% and 35% by weight, and even more preferentially between 1% and 30% by weight, better still between 1.5% and 25% by weight and even better still between 2% and 20% by weight relative to the total weight of the composition.
[0215] For the purposes of the present invention, the term “total amount of UV screening agents” means the sum of the concentrations of each of the UV screening agents present in the composition, more particularly organic UV screening agents and inorganic UV screening agents.Solvents
[0216] According to a particular embodiment, the compositions in accordance with the invention comprise at least one additional organic solvent.
[0217] According to the invention, an organic solvent is liquid at room temperature (25°C) and atmospheric pressure (760 mmHg).
[0218] According to a particular embodiment, the organic solvent(s) may in particular be chosen from oils, polyols, monoalcohols, or mixtures thereof.
[0219] According to another particular embodiment, the solvent or solvents of the invention are volatile cosmetic solvents, which are liquid at room temperature, having a vapor pressure, at room temperature and atmospheric pressure, of greater than or equal to 0.13 Pa, preferably greater than or equal to 1.3 Pa, preferentially greater than or equal to 3 Pa, more preferentially greater than or equal to 10 Pa, even more preferentially greater than or equal to 20 Pa, even better still greater than or equal to 50 Pa, and much better still greater than or equal to 100 Pa.Oils
[0220] According to a particular embodiment, the compositions in accordance with the invention comprise at least one oil.
[0221] The term “oil” means any fatty substance that is in liquid form at room temperature (25°C) and at atmospheric pressure (760 mmHg). These oils may be volatile or non-volatile.
[0222] The term “non-volatile oil” means an oil that remains on the skin or the keratin fiber at room temperature and atmospheric pressure for at least several hours, and that notably has a vapor pressure of less than 10-3mmHg (0.13 Pa).
[0223] For the purposes of the invention, the term “volatile oil” means an oil that is capable of evaporating on contact with the skin or the keratin fiber in less than one hour, at room temperature and atmospheric pressure. The volatile oil or oils of the invention are volatile cosmetic oils, liquid at room temperature, having a nonzero vapor pressure at room temperature and atmospheric pressure, in particular of greater than or equal to 10-3mmHg (0.13 Pa), preferably greater than or equal to 1.3 Pa, preferentially greater than or equal to 3 Pa, more preferentially greater than or equal to 10 Pa, even more preferentially greater than or equal to 20 Pa, even better still greater than or equal to 50 Pa, and much better still greater than or equal to 100 Pa.
[0224] According to a particular embodiment, the vapor pressure of volatile oils ranges from 0.13 Pa to 40,000 Pa (10-3to 300 mmHg), in particular from 1.3 Pa to 13,000 Pa (0.01 to 100 mmHg), and more particularly from 1.3 Pa to 1300 Pa (0.01 to 10 mmHg).
[0225] According to a particular embodiment, the composition in accordance with the invention may comprise at least one hydrocarbon-based oil.
[0226] For the purposes of the present invention, the term “hydrocarbon-based oil” means any oil predominantly comprising carbon and hydrogen atoms, and optionally one or more heteroatoms, in particular nitrogen and oxygen. Thus, these oils may notably contain one or more ester, ether, fluoro, carboxylic acid and / or alcohol groups.
[0227] As non-volatile hydrocarbon-based oils that can be used according to the invention, mention may notably be made of:(i) hydrocarbon-based oils of plant origin, such as glyceride triesters, which are generally fatty acid triesters of glycerol, the fatty acids of which may have varied chain lengths from C4to C24, these chains possibly being linear or branched, and saturated or unsaturated; these oils are notably wheatgerm oil, sunflower oil, grapeseed oil, sesame seed oil, corn oil, apricot oil, castor oil, shea oil, avocado oil, olive oil, soybean oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, hazelnut oil, macadamia oil, jojoba oil, alfalfa oil, poppy oil, pumpkin oil, sesame seed oil, marrow oil, rapeseed oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passion flower oil and musk rose oil; or alternatively caprylic / capric acid triglycerides such as those sold by the company Stéarinerie Dubois or those sold under the names Miglyol 810®, 812® and 818® by the company Dynamit Nobel;(ii) synthetic ethers having from 10 to 40 carbon atoms, such as the dicaprylyl ether sold under the name Cetiol EO by the company BASF;(iii) linear or branched hydrocarbons of mineral or synthetic origin, such as petroleum jelly, polydecenes, hydrogenated polyisobutene, such as Parleam, squalane and mixtures thereof;(iv) synthetic esters, such as the oils of formula RCOOR’ in which R represents the residue of a linear or branched fatty acid comprising from 1 to 40 carbon atoms and R’ represents a hydrocarbon chain that is notably branched, containing from 1 to 40 carbon atoms, with the proviso that R + R’ ≥ 10, for instance purcellin oil (cetostearyl octanoate), isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoate, such as the product sold under the trade name Finsolv TN® or Witconol TN® by the company Witco or Tegosoft TN® by the company Evonik Goldschmidt, 2-ethylphenyl benzoate, such as the commercial product sold under the name X-Tend 226® by the company ISP, isopropyl lanolate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, oleyl erucate, 2-ethylhexyl palmitate, isostearyl isostearate, diisopropyl sebacate such as the product sold under the name Dub Dis by the company Stéarinerie Dubois, alcohol or polyalcohol octanoates, decanoates or ricinoleates, such as propylene glycol dioctanoate; hydroxylated esters, such as isostearyl lactate, diisostearyl malate; and pentaerythritol esters; citrates or tartrates, such as linear C12-C13 dialkyl tartrates, such as those sold under the name Cosmacol ETI® by the company Enichem Augusta Industriale, and also linear C14-C15 dialkyl tartrates such as those sold under the name Cosmacol ETL® by the same company; acetates;(v) fatty alcohols that are liquid at room temperature, bearing a branched and / or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol or 2-undecylpentadecanol;(vi) higher C12-C22 fatty acids, such as oleic acid, linoleic acid or linolenic acid;(vii) carbonates, such as dicaprylyl carbonate, such as the product sold under the name Cetiol CC® by the company Cognis; and mixtures thereof.
[0228] Among the non-volatile hydrocarbon-based oils which can be used according to the invention, preference will be given more particularly to glyceride triesters and in particular to caprylic / capric acid triglycerides, synthetic esters and ethers and more particularly dicaprylyl ether, diisopropyl adipate, diisopropyl sebacate, isopropyl palmitate, isopropyl myristate, dicaprylyl carbonate, isononyl isononanoate, oleyl erucate, C12-C15 alcohol benzoate, 2-ethylphenyl benzoate and fatty alcohols, and particularly octyldodecanol. Preferably, the non-volatile hydrocarbon-based oils are chosen from dicaprylyl ether, diisopropyl adipate, diisopropyl sebacate, isopropyl palmitate, isopropyl myristate, dicaprylyl carbonate and C12-15 alkyl benzoate.
[0229] As volatile hydrocarbon-based oils which can be used according to the invention, mention may be made in particular of hydrocarbon oils having from 8 to 16 carbon atoms, and in particular branched C8-C16 alkanes such as C8-C16 isoalkanes such as isododecane (also called 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, the oils sold under the trade names Isopars or Permetyls, the linear hydrocarbons of the INCI name C9-12 Alkane sold under the trade name Vegelight Silk 100 by the company Biosynthis, the branched hydrocarbons of the INCI name C15-19 Alkane sold under the names Emogreen L15 and Emogreen L19 sold by the company SEPPIC, the branched C8-C16 esters, isohexyl neopentanoate, and mixtures thereof.
[0230] Mention may also be made of the alkanes described in the Cognis patent applications WO 2007 / 068371 or WO 2008 / 155059 (mixtures of different alkanes differing by at least one carbon). These alkanes are obtained from fatty alcohols, which are themselves obtained from coconut kernel oil or palm oil. Mention may be made of mixtures of n-undecane (C11) and of n-tridecane (C13) obtained in examples 1 and 2 of patent application WO 2008 / 155059. Mention may be made in particular of mixtures based on undecane and tridecane, such as those marketed under the name Cetiol UT by the company BASF, and also n-dodecane (C12) and n-tetradecane (C14) sold by Sasol under the references PARAFOL 12-97 and PARAFOL 14-97® respectively, and also mixtures thereof.
[0231] Other volatile hydrocarbon-based oils, such as petroleum distillates, in particular those sold under the name Shell Solt® by Shell, can also be used. According to one embodiment, the volatile solvent is chosen from volatile hydrocarbon-based oils having from 8 to 16 carbon atoms and mixtures thereof.
[0232] According to one particular embodiment of the invention, the composition comprises at least one volatile oil. According to a preferred embodiment, the composition according to the invention comprises at least one volatile oil chosen from hydrocarbon oils consisting solely of carbon and hydrogen atoms. Preferably, the composition comprises at least one oil chosen from linear C8-C20 alkanes such as C9-C12 or C15-C19 alkanes, mixtures of n-undecane (C11) and n-tridecane (C13), n-dodecane (C12) and n-tetradecane (C14), or branched C8-C16 alkanes such as C8-C16 isoalkanes, especially isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, and mixtures thereof.
[0233] When the composition according to the invention comprises at least one oil, the oil or oils are present in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.Polyols
[0234] According to a particular embodiment, the composition in accordance with the present invention comprises one or more C2-C10, preferably C2-C6 and more preferentially C2-C4 polyols.
[0235] For the purposes of the present invention, the term “polyol” means an organic compound consisting of a hydrocarbon-based chain comprising from 2 to 10 carbon atoms, preferably from 2 to 6 carbon atoms, and more preferentially from 2 to 4 carbon atoms, optionally interrupted with one or more oxygen atoms and bearing at least two free hydroxyl groups (-OH) borne by different carbon atoms, this compound possibly being cyclic or acyclic, linear or branched, and saturated or unsaturated.
[0236] These polyols may be volatile or non-volatile. Preferably, the polyol(s) present in the composition of the invention are volatile.
[0237] The term “non-volatile polyol” means a polyol that remains on the skin or the keratin fiber at room temperature and atmospheric pressure for at least several hours, and that notably has a vapor pressure of less than 10-3mmHg (0.13 Pa).
[0238] For the purposes of the invention, the term “volatile polyol” means a polyol that is capable of evaporating on contact with the skin or the keratin fiber in less than one hour, at room temperature and atmospheric pressure. The volatile polyol or polyols of the invention are volatile cosmetic polyols, liquid at room temperature, having a nonzero vapor pressure at room temperature and atmospheric pressure, in particular of greater than or equal to 10-3mmHg (0.13 Pa), preferably greater than or equal to 1.3 Pa, preferentially greater than or equal to 3 Pa, more preferentially greater than or equal to 10 Pa, even more preferentially greater than or equal to 20 Pa, even better still greater than or equal to 50 Pa, and much better still greater than or equal to 100 Pa.
[0239] According to a particular embodiment, the vapor pressure of the volatile polyols ranges from 0.13 Pa to 40 000 Pa (10-3to 300 mmHg), in particular from 1.3 Pa to 13 000 Pa (0.01 to 100 mmHg), and more particularly from 1.3 Pa to 1300 Pa (0.01 to 10 mmHg).
[0240] According to a particular embodiment, the polyol or polyols used in the context of the invention are chosen from propylene glycol, propane-1,3-diol, 1,3-butylene glycol, pentane-1,2-diol, dipropylene glycol, hexylene glycol, caprylyl glycol, polyethylene glycols, glycerin, and mixtures thereof.
[0241] Preferably, the polyol or polyols used in the context of the invention are chosen from propylene glycol, propane-1,3-diol, 1,3-butylene glycol, pentane-1,2-diol, dipropylene glycol, hexylene glycol, and mixtures thereof, even more preferably from propylene glycol, propane-1,3-diol, 1,3-butylene glycol, pentane-1,2-diol, and mixtures thereof.
[0242] According to a particular embodiment of the invention, the one or more C2-C10 polyols are present in the composition in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.C2-C6 monoalcohol
[0243] According to a particular embodiment, the composition in accordance with the invention comprises at least one C2-C6 monoalcohol.
[0244] The one or more monoalcohols in accordance with the invention comprise from 2 to 6 carbon atoms, and in particular from 2 to 4 carbon atoms and mixtures thereof.
[0245] The monoalcohol(s) may be represented, for example, by the formula RaOH, in which Ra represents a linear or branched alkyl group comprising from 2 to 6 carbon atoms.
[0246] These alcohols may be volatile or non-volatile. Preferably, the one or more polyols present in the composition of the invention are volatile.
[0247] The term “non-volatile alcohol” means an alcohol that remains on the skin or the keratin fiber at room temperature and atmospheric pressure for at least several hours, and that notably has a vapor pressure of less than 10-3mmHg (0.13 Pa).
[0248] For the purposes of the invention, the term “volatile alcohol” means an alcohol that is capable of evaporating on contact with the skin or the keratin fiber in less than one hour, at room temperature and atmospheric pressure. The volatile alcohol or alcohols of the invention are volatile cosmetic alcohols, liquid at room temperature, having a nonzero vapor pressure at room temperature and atmospheric pressure, in particular of greater than or equal to 10-3mmHg (0.13 Pa), preferably greater than or equal to 1.3 Pa, preferentially greater than or equal to 3 Pa, more preferentially greater than or equal to 10 Pa, even more preferentially greater than or equal to 20 Pa, even better still greater than or equal to 50 Pa, and much better still greater than or equal to 100 Pa.
[0249] According to a particular embodiment, the vapor pressure of the volatile monoalcohols ranges from 0.13 Pa to 40 000 Pa (10-3to 300 mmHg), in particular from 1.3 Pa to 13 000 Pa (0.01 to 100 mmHg), and more particularly from 1.3 Pa to 5000 Pa (0.01 to 10 mmHg).
[0250] Monoalcohols that may be mentioned include ethanol, isopropanol, propanol or butanol, and more particularly ethanol.
[0251] According to a preferred form of the invention, the one or more C2-C6 mono-alcohols are present in the composition of the invention in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.Cosmetic active ingredients
[0252] The composition of the present invention may comprise at least one cosmetic active agent.
[0253] Examples of cosmetic active agents that may be mentioned include moisturizers; natural extracts; vitamins and derivatives thereof; alpha-hydroxy acids; retinoids; extracts of algae, fungi, plants, yeasts and bacteria; enzymes; tautening agents; agents acting on the microcirculation, and mixtures thereof.
[0254] A person skilled in the art can readily adjust the amount of cosmetic active principle according to the end use of the composition according to the present invention.Additional adjuvants or additives
[0255] The composition of the present invention may also comprise or contain conventional cosmetic adjuvants or additives, for example fragrances, chelating agents, preservatives and bactericides, additional thickeners, additional fillers, and mixtures thereof.
[0256] A person skilled in the art can select the amount of additional adjuvants or additives so as not to adversely affect the end use of the composition according to the present invention.Presentation forms
[0257] The compositions according to the invention may be prepared according to techniques that are well known to a person skilled in the art.
[0258] According to a particular embodiment, the compositions according to the invention are in aqueous form, for example in the form of an aqueous gel or aqueous-alcoholic composition, but also in the form of an emulsion, notably an oil-in-water or water-in-oil, or two-phase, emulsion.
[0259] According to a preferred embodiment, the composition of the invention does not comprise an oily phase. Preferably, the compositions according to the invention are oil-free. For the purposes of the invention, the term “oil-free” denotes a composition comprising only one liquid phase, which is an aqueous phase (a liquid phase comprising water). The term “oil” does not cover, for example, water-soluble active ingredients, water-soluble or water-dispersible UV screening agents, water-soluble alcohols and water-soluble glycols.
[0260] According to another particular embodiment, the composition according to the invention is in the form of an emulsion. When the composition according to the invention is in the form of an oil-in-water emulsion, it comprises an oily phase dispersed in an aqueous phase. When the composition according to the invention is in the form of a water-in-oil emulsion, it comprises an aqueous phase dispersed in an oily phase.
[0261] The emulsions may generally contain at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture. The emulsifiers are chosen appropriately according to the emulsion to be obtained (W / O or O / W).
[0262] According to a particular embodiment, the composition in accordance with the invention is an anhydrous composition.
[0263] “Anhydrous composition” means a composition characterized by an absence of water or the presence of water in an amount such that qualified persons can determine that it is free or substantially free of water. For example, an “anhydrous” composition according to the present invention may comprise less than 10%, notably less than 5%, in particular less than 2%, better still less than 1% by weight, preferably less than 0.5% by weight of water, relative to the total weight of the composition. Preferably, an “anhydrous” composition according to the present invention does not comprise a detectable amount of water, the “detectable amount” signifying an amount that can be detected by a device conventionally used in the art to measure the water content.
[0264] The compositions in accordance with the invention are preferably anhydrous.
[0265] The compositions according to the invention find their application in a large number of treatments, notably cosmetic treatments, for the skin, the lips and the hair, including the scalp, notably for protecting and / or caring for the skin, the lips and / or the hair, and / or for making up the skin and / or the lips.
[0266] Another subject of the present invention consists of the use of the compositions according to the invention as defined above for the manufacture of products for the cosmetic treatment of the skin, the lips, the nails, the hair, the eyelashes, the eyebrows and / or the scalp, notably care products, antisun products and makeup products.EXAMPLES
[0267] The present invention will now be described more specifically by means of examples, which do not in any way limit the scope of the invention. However, the examples make it possible to support specific features, variants and preferred embodiments of the invention.Formulation examples
[0268] In these examples, the amounts of the ingredients are given as % by weight of starting materials relative to the total weight of the composition.
[0269] Protocol for evaluating the homogeneity of solutions
[0270] In the examples which follow, the homogeneity is evaluated macroscopically, with the naked eye. It is evaluated at room temperature, on the day the solution is prepared and then over time. During this time period, the solutions are stored at room temperature.
[0271] Solutions are considered homogeneous if, at room temperature, the solution appears to the naked eye as having only one phase without phase alteration or separation.Comparative examples 1 to 4
[0272] The following solutions were prepared according to the process below.Ingredients1(outside of the invention)2(outside of the invention)3(invention)4(invention)Mixture (25 / 75) of elastomer gel* / immiscible isododecane35 g35 g35 g35 gSilica Silylate(Dowsil VM-2270 Aerogel Fine Particles from Dow)--2 g-Silica Dimethyl Silylate(Aerosil R 972 from Evonik Degussa)---2 gSilica(Solesphere H 51 from AGC Si-Tech)-2 g--Results / ObservationsInhomogeneousInhomogeneousHomogeneousHomogeneous
[0273] *COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE elastomer gel marketed under the name HARMONIE NATUVEL GEL by Momentive
[0274] Method of preparation of compositions 1 to 4Preparation of the mixture of elastomer in these solvents and isododecane (ratio Momentive / isododecane = 25 / 75):Introduction of the ingredients into a 50 g jar of a Hauschild speedmixer, model DAC150.1 FVZ; then mixing of the ingredients with the speedmixer for 1 minute at 2000 rpm.Spatula addition of fillers and coarse homogenization.Homogenization with the speedmixer for 1 minute at 2000 rpm.All operations are performed at room temperature.
[0275] Results:These comparative examples show that hydrophobic silicas in accordance with the invention, in particular Silica Silylate and Silica Dimethyl Silylate, make it possible to obtain a homogeneous solution of elastomer gel of the INCI name COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE marketed under the name HARMONIE NATUVEL GEL by Momentive in isododecane.Comparative examples 5 to 8
[0276] The following solutions were prepared according to the process below.Ingredients5(outside of the invention)6(outside of the invention)7(invention)8(outside of the invention)9(invention)Mixture (25 / 75) of elastomer gel* / immiscible ethanol35 g35 g35 g35 g35 gSilica Silylate(Dowsil VM-2270 Aerogel Fine Particles from Dow)--2 g-Silica Dimethyl Silylate(Aerosil R 972 from Evonik Degussa)----6 gSilica(Solesphere H 51 from AGC Si-Tech)-2 g-6 g-Results / ObservationsInhomogeneousInhomogeneousHomogeneousInhomogeneousHomogeneous
[0277] *COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE elastomer gel marketed under the name HARMONIE NATUVEL GEL by Momentive
[0278] Method of preparation of compositions 5 to 9Preparation of the mixture of elastomer in these solvents and isododecane (ratio Momentive / isododecane = 25 / 75):Introduction of the ingredients into a 50 g jar of a Hauschild speedmixer, model DAC150.1 FVZ; then mixing of the ingredients with the speedmixer for 1 minute at 2000 rpm.Spatula addition of fillers and coarse homogenization.Homogenization with the speedmixer for 1 minute at 2000 rpm.All operations are performed at room temperature.
[0279] Results:These comparative examples show that hydrophobic silicas in accordance with the invention, in particular Silica Silylate and Silica Dimethyl Silylate, make it possible to obtain a homogeneous solution of elastomer gel of the INCI name COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE marketed under the name HARMONIE NATUVEL GEL by Momentive in ethanol.Illustrative examples
[0280] The following composition was prepared according to the process below.PhaseINCI nameConcentration (%m)A1BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE5A1DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE5A1ETHYLHEXYL TRIAZONE4.8A1DROMETRIZOLE TRISILOXANE1A1COCO-CAPRYLATE / CAPRATE (and) POLYGLYCERYL-2 ISOSTEARATE / DIMER DILINOLEATE COPOLYMER (and) SQUALANE(HARMONIE NATUVEL GEL from Momentive)5A1DIISOPROPYL SEBACATE8A1C12-15 ALKYL BENZOATE4.5A1DICAPRYLYL CARBONATE15A2ISOPROPYL MYRISTATE18.45A2TOCOPHEROL1A3SILICA7A4SILICA SILYLATE5.25A5ISODODECANE7A6DENAT. ALCOHOL13
[0281] Preparation protocolProtocol carried out on 1 kg with a 2.7 L Olsa Minilab 2G.Introduce all ingredients of phase A1 into a beaker, with heating to 75°C, with turbining at 1700 rpm until a perfectly homogeneous and clear mixture is obtained.
[0282] Add phase A2 ingredients (isopropyl myristate and tocopherol) while maintaining stirring at 1000 rpm to a temperature of 30°C.
[0283] Introduce silica (phase A3) with stirring at 1700 rpm until a homogeneous mixture is obtained.
[0284] Add the hydrophobic silica with stirring at 4000 rpm until the fillers are completely dispersed.
[0285] Introduce isododecane while maintaining stirring at 1700 rpm. Make sure the temperature is 30°C or less.
[0286] Once the mixture is at 20°C, add ethanol, with stirring at 1700 rpm until a homogeneous mixture is obtained.
Claims
A composition, in particular a cosmetic or dermatological composition, comprising:(a) an elastomer gel containing at least one crosslinked polyester elastomer and at least one solvent; and(b) hydrophobic silica particles;wherein the elastomer contains a reaction product of: (i) at least one dicarboxylic acid or tricarboxylic acid; (ii) at least one monocarboxylic acid; and (iii) at least one polyol;the one or more dicarboxylic acids being chosen from the compounds of formula (IA):wherein R1A is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the tricarboxylic acid(s) being chosen from the compounds of formula (IB):wherein R1B is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group;the monocarboxylic acid(s) being chosen from the compounds of formula (II):wherein R2 is a C2-C52 alkyl group, a C2-C52 heteroalkyl group, a C2-C52 alkenyl group, a C2-C52 heteroalkenyl group, a C3-C52 cyclic group or a C2-C52 heterocyclic group,and the one or more polyols being chosen from the compounds of formula (III):wherein R3 is a C3-C50 alkyl group, a C3-C50 heteroalkyl group, a C3-C50 alkenyl group, a C3-C50 heteroalkenyl group, a C3-C50 cyclic group or a C3-C50 heterocyclic group; and n is an integer from 2 to 10.The composition as claimed in claim 1, wherein the crosslinked polyester elastomer gel contains about 30% by weight of at least one elastomer in a solvent comprising coco-caprylate / caprate and squalane.The composition as claimed in either one of claims 1 and 2, wherein the elastomer comprises a polyglyceryl-2 isostearate / dilinoleate dimer copolymer.The composition as claimed in any one of claims 1 to 3, wherein the crosslinked polyester elastomer is present in an amount of between 0.1% and 50% by weight, preferably between 0.2% and 30% by weight, preferably between 0.3% and 15% by weight, preferably between 0.5% and 10% by weight, and even more preferentially between 1% and 5% by weight, relative to the total weight of the composition.The composition as claimed in any one of claims 1 to 4, wherein the crosslinked polyester elastomer is present in an amount of between 0.03% and 15% by weight, preferably between 0.06% and 9% by weight, preferably between 0.09% and 4.5% by weight, preferably between 0.15% and 3% by weight, and even more preferentially between 0.3% and 1.5% by weight relative to the total weight of the composition.The composition as claimed in any one of claims 1 to 5, wherein the hydrophobic silica particles are in the form of hydrophobic aggregates.The composition as claimed in any one of claims 1 to 6, wherein the hydrophobic silica particles are chosen from hydrophobic silica aerogel particles surface-modified with trimethylsilyl groups.The composition as claimed in any one of claims 1 to 7, wherein the hydrophobic silica particles are present in an amount ranging from 0.1% to 10% by weight, preferably from 0.5% to 10% by weight, and more preferentially from 1% to 8% by weight, better still from 1.5% to 7% by weight and even better still from 2% to 5% by weight relative to the total weight of the composition.The composition as claimed in any one of claims 1 to 8, comprising at least one volatile or non-volatile, preferably volatile, organic solvent.The composition as claimed in claim 9, wherein the one or more organic solvents are chosen from oils, preferably hydrocarbon oils, polyols, monoalcohols, or mixtures thereof.The composition as claimed in any one of claims 1 to 10, comprising at least one volatile oil, preferably chosen from hydrocarbon oils consisting solely of carbon and hydrogen atoms, more preferably chosen from linear C8-C20 alkanes such as C9-C12 or C15-C19 alkanes, mixtures of n-undecane (C11) and n-tridecane (C13), n-dodecane (C12) and n-tetradecane (C14), or branched C8-C16 alkanes such as C8-C16 isoalkanes, and particularly isododecane (also known as 2,2,4,4,6-pentamethylheptane), isodecane, isohexadecane, and mixtures thereof.The composition as claimed in claim 11, wherein the one or more volatile oils are present in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.The composition as claimed in any one of claims 1 to 12, comprising at least one polyol, preferably chosen from propylene glycol, propane-1,3-diol, 1,3-butylene glycol, pentane-1,2-diol, dipropylene glycol, hexylene glycol, and mixtures thereof, more preferably chosen from propylene glycol, propane-1,3-diol, 1,3-butylene glycol, pentane-1,2-diol, and mixtures thereof.The composition as claimed in claim 13, wherein the one or more polyols are present in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.The composition as claimed in any one of claims 1 to 14, comprising at least one C2-C6, preferably C2-C4 monoalcohol, more preferably chosen from ethanol, isopropanol, propanol, butanol, and mixtures thereof, and even more preferably ethanol.The composition as claimed in claim 15, wherein the one or more monoalcohols are present in contents ranging from 0.05% to 99% by weight, preferably from 0.1% to 75% by weight, preferentially from 0.2% to 50% by weight, more preferentially from 0.3% to 20% by weight, even more preferentially from 0.5% to 10% by weight, better still from 1% to 5% by weight and even better still from 1% to 3% by weight relative to the total weight of said composition.The composition as claimed in any one of claims 1 to 16, comprising a mixture of volatile hydrocarbon oil(s) and of monoalcohol(s); preferably, the one or more volatile hydrocarbon oils are chosen from isododecane, a mixture of undecane and tridecane, and mixtures thereof, and the monoalcohol is ethanol.The composition as claimed in any one of claims 1 to 17, further comprising one or more UV screening agents, preferably one or more organic UV screening agents, and even more preferentially one or more lipophilic organic UV screening agents.The composition as claimed in any one of claims 1 to 18, which is anhydrous.
